###begin article-title 0
Mutations that are a common cause of Leber congenital amaurosis in northern America are rare in Southern India
###end article-title 0
###begin title 1
Purpose
###end title 1
###begin p 2
###xml 8 16 <span type="species:ncbi:9606">patients</span>
To test patients from southern India for the presence of mutations that most commonly cause Leber congenital amaurosis (LCA) in northern America.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AIPL1</italic>
###xml 177 181 177 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRB1</italic>
###xml 203 206 203 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRX</italic>
###xml 231 237 231 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GUCY2D</italic>
###xml 260 265 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPHP6</italic>
###xml 294 299 294 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RDH12</italic>
###xml 354 359 354 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPE65</italic>
###xml 427 434 427 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPGRIP1</italic>
###xml 532 540 <span type="species:ncbi:9606">patients</span>
A review of the literature identified 177 unique LCA causing mutations in eight different genes: aryl hydrocarbon receptor interacting protein-like 1 (AIPL1), crumbs homolog 1 (CRB1), cone-rod homeobox (CRX), guanylate cyclase 2D (GUCY2D), nephronophthisis 6 (NPHP6), retinol dehydrogenase 12 (RDH12), retinal pigment epithelium-specific protein 65 kDa (RPE65), and retinitis pigmentosa GTPase regulator interacting protein 1 (RPGRIP1). Allele-specific ligation assay and bidirectional sequencing were used to test 38 unrelated LCA patients from southern India for 104 of these mutations, which contribute to more than 30% of the LCA cases in a northern American population.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 107 112 107 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPE65</italic>
###xml 179 184 179 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPE65</italic>
###xml 9 20 <span type="species:ncbi:9606">participant</span>
###xml 234 241 <span type="species:ncbi:9606">patient</span>
Only one participant was found to harbor one of the 104 mutations in the allele-specific assay (homozygous RPE65 Tyr368His). A mutation that was not part of the assay (homozygous RPE65 Tyr143Asp) was incidentally detected in a second patient when an equivocal signal from one allele on the assay was followed up with automated DNA sequencing.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 197 202 197 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPHP6</italic>
###xml 589 597 <span type="species:ncbi:9606">patients</span>
Mutations that contribute to 30% of the LCA cases in northern America were detected in only 2.6% of LCA cases in our cohort from southern India. There were no instances of IVS26 c.2991+1655 A>G in NPHP6, the most commonly detected mutation in LCA. These data suggest that LCA in India is caused primarily by a different set of mutations in the same genes associated with disease in northern America, or by mutations in other genes that have not yet been discovered. Therefore, mutation-specific assays developed for European and northern American cohorts may not be suited for testing LCA patients from India or other ethnically distinct populations.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 319 320 319 320 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">:</bold>
###xml 375 381 375 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AIPL1)</italic>
###xml 383 384 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 405 410 405 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRB1)</italic>
###xml 412 413 412 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 435 439 435 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRX)</italic>
###xml 441 442 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 467 473 467 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GUCY2D</italic>
###xml 475 481 475 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETGC1</italic>
###xml 484 485 484 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 527 534 527 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IMPDH1)</italic>
###xml 536 537 536 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 570 575 570 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LCA5)</italic>
###xml 577 578 577 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 614 620 614 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(LRAT)</italic>
###xml 622 623 622 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 646 659 646 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPHP6; CEP290</italic>
###xml 662 663 662 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 692 698 692 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RDH12)</italic>
###xml 700 701 700 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 728 732 728 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RD3)</italic>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 791 797 791 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPE65)</italic>
###xml 799 801 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 869 877 869 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPGRIP1)</italic>
###xml 879 881 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 906 912 906 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TULP1)</italic>
###xml 914 916 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 917 919 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 1087 1089 1087 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 1090 1092 1090 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 1260 1262 1260 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 1046 1054 <span type="species:ncbi:9606">patients</span>
###xml 1250 1258 <span type="species:ncbi:9606">patients</span>
Leber congenital amaurosis (LCA; OMIM ) is a term used to describe a heterogenous and typically autosomal recessive group of inherited retinal dystrophies characterized by: severe visual impairment at birth; normal-appearing retina; and profoundly reduced electroretinogram. Thirteen genes have been associated with LCA: aryl hydrocarbon receptor interacting protein-like 1 (AIPL1) [1], crumbs homolog 1 (CRB1) [2], cone-rod homeobox (CRX) [3], guanylate cyclase 2D (GUCY2D; RETGC1) [4], inosine monophosphate dehydrogenase 1 (IMPDH1) [5], Leber congenital amaurosis 5 (LCA5) [6], lecithin retinol acyltransferase (LRAT) [7], nephronophthisis 6 (NPHP6; CEP290) [8], retinol dehydrogenase 12 (RDH12) [9], retinal degeneration 3 (RD3) [10], retinal pigment epithelium-specific protein 65 kDa (RPE65) [11], and retinitis pigmentosa GTPase regulator interacting protein 1 (RPGRIP1) [12], tubby like protein 1 (TULP1) [13,14]. The frequency of disease-associated mutations among eight of these genes has recently been assessed in large populations of patients, using a range of technologies [15-18]. Many of the variations detected in these studies were only rarely observed, but nearly 100 different variations were detected in two or more unrelated LCA patients [18].
###end p 10
###begin p 11
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GUCY2D</italic>
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPE65,</italic>
###xml 46 49 46 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRX</italic>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 215 220 215 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPE65</italic>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 357 360 357 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RD3</italic>
###xml 901 903 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 71 79 <span type="species:ncbi:9606">patients</span>
###xml 276 284 <span type="species:ncbi:9606">patients</span>
###xml 433 441 <span type="species:ncbi:9606">patients</span>
###xml 573 581 <span type="species:ncbi:9606">patients</span>
###xml 808 816 <span type="species:ncbi:9606">patients</span>
###xml 934 942 <span type="species:ncbi:9606">patients</span>
In one study, mutations in GUCY2D, RPE65, and CRX were detected in LCA patients from India, although at lower frequency than previously reported in cohorts from northern America [19]. In another study, mutations in RPE65 were similarly detected in a smaller proportion of LCA patients from India than in northern America [20]. Finally, a 2006 [10] study of RD3 identified a mutation in an Indian family, but found no examples in LCA patients from northern America. Although these studies have explored the role of some previously discovered LCA genes in causing disease in patients from India, no comprehensive investigation of multiple genes has been performed on this population. We set out to determine the frequencies of mutations associated with LCA in the Indian population by testing 38 unrelated LCA patients from India for 104 previously identified mutations in eight genes. In a 2007 study [18] of 642 northern American LCA patients, 49 of these 104 mutations cumulatively contributed to more than 30% of LCA cases.
###end p 11
###begin title 12
Methods
###end title 12
###begin p 13
###xml 212 224 <span type="species:ncbi:9606">participants</span>
###xml 226 234 <span type="species:ncbi:9606">Patients</span>
###xml 364 372 <span type="species:ncbi:9606">patients</span>
The study received approval from the Ethical Review Board of Aravind Eye Care System in India, and the Institutional Review Board of the University of Iowa (Iowa City, IA). Informed consent was obtained from all participants. Patients were examined at the Aravind Eye Hospital (Madurai, India), a regional facility serving a large area of southern India. As such, patients and controls recruited for this study represent an unselected sampling of the South Indian population. A total of 41 unrelated individuals were enrolled in this study as probands after a diagnosis of LCA. Probands were from 6 months to 12 years of age at enrollment (mean 5.0 years SD+/-3.3), 24 female and 17 male, and in good health. Diagnosis of LCA was based on the following criteria: 1) severely reduced vision in both eyes that was recognized within two years of birth; 2) relatively normal appearance of the retina; 3) profoundly reduced or nonrecordable ISCEV electroretinogram; and 4) absence of symptoms that would suggest another disease. When possible, relatives were also assessed and included in the study for assessment of inheritance phase. A total of 84 family members were enrolled, this included: 74 parents (0 affected; 33 male, 41 female; mean age 32.2 years SD+/-7.5), and 12 siblings (2 affected, 1 female aged 2 and 1 male aged 7; 10 unaffected, 6 male, and 4 female; mean age 10.7 years SD+/-4.0). Although each proband was unrelated, consanguinity was identified from histories in the families of 34 of 41 probands (83%). Additionally, 25 unrelated healthy individuals were used as control study subjects.
###end p 13
###begin title 14
DNA preparation
###end title 14
###begin p 15
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 514 519 514 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPHP6</italic>
###xml 322 334 <span type="species:ncbi:9606">participants</span>
Peripheral blood (approximately 10 ml) was collected using vacutainer EDTA (EDTA) tubes (Becton-Dickinson, Franklin Lakes, NJ), and DNA was extracted by salt precipitation [21]. Blood samples were obtained from 41 unrelated affected individuals with LCA. However, the concentration of the DNA obtained from three of these participants was inadequate for the allele-specific ligation assay. Consequently, only 38 individuals were studied with both the allele-specific ligation assay and bidirectional sequencing of NPHP6, as will be described.
###end p 15
###begin title 16
Allele-specific ligation assay
###end title 16
###begin p 17
###xml 28 34 28 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GUCY2D</italic>
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPE65</italic>
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRB1</italic>
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AIPL1</italic>
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRX</italic>
###xml 61 66 61 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RDH12</italic>
###xml 72 79 72 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPGRIP1</italic>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 888 895 888 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
LCA-associated mutations in GUCY2D, RPE65, CRB1, AIPL1, CRX, RDH12, and RPGRIP1 have been well characterized in northern American populations [18]. A total of 177 previously reported mutations in these genes were identified in a review of the literature. A multiplexed allele-specific assay was designed to detect 138 of these mutations using the SNPlex platform (Applied Biosystems, Foster City, CA). Four of the 138 probes were subsequently found to be benign polymorphisms [18], or evidence for disease causing status was inconclusive (RPGRIP1 ARG812GLN). These probes were therefore excluded from analysis. Of the remaining 134 plausible disease-causing alleles, technical limitations in the probe sets meant the assay was unable to reliably detect either allele for 31 single nucleotide polymorphisms (SNPs). Consequently, genotypic data from 103 SNPs were included in our analysis (Table 1).
###end p 17
###begin title 18
Genotypes for deliberately assessed alleles.
###end title 18
###begin p 19
The presence or absence of LCA-causing alleles as assessed by SNPlex allele specific ligation assay and bidirectional sequencing (NPHP6 IVS26 c.2991+1655 only) are shown by gene. For each allele assessed, the number of proband samples identified as homozygous normal (NL), heterozygous for a disease causing allele (Mut - Het) or homozygous for a disease causing allele (Mut - Homo) are shown. Any discrepancy between the sum of these numbers and the 38 samples assayed is due to failed allele calls.
###end p 19
###begin p 20
DNA sample preparation, allele-specific ligation, and post-ligation amplification were performed in 96 well plates according to the manufacturer's instructions (SNPlex, Applied Biosystems). PCR products were analyzed with a 3730 DNA sequencer and GeneMapper software (Applied Biosystems). Allele status was initially assigned using custom software developed at the University of Iowa, and allele assignments were then confirmed manually. In some cases, genotypes could not be reliably assigned because of low probe signal strength (below 500 units for both normal and mutant alleles). In total 51 of 3,914 genotypes (1.3%) were excluded for this reason.
###end p 20
###begin p 21
###xml 403 404 395 396 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 252 259 <span type="species:ncbi:9606">patient</span>
Positive results from the allele-specific assay were verified by bidirectional sequencing of an amplimer spanning the mutation in question. Confirmed mutations were assessed in relatives of the probands to establish phase. Approximately 150 ng of each patient's DNA was used as template in a 30.0 microl PCR containing the following: 3.0 microl 10X buffer (100 mM Tris-HCl pH 8.3, 500 mM KCl, 15 mM MgCl2), 9 mM of each dCTP, dATP, dGTP, and dTTP, 9 pmole of each primer (Integrated DNA Technologies, Coralville, IA), and 0.9 units of DNA polymerase (Biolase, Irvine, CA). Samples were denatured for 5 min at 94 degreesC and incubated for 35 cycles under the following conditions: 94 degreesC for 30 s, 57 degreesC for 30 s, 72 degreesC for 30 s in an MJ Research DNA thermocycler (BioRad, Waltham, MA). PCR products were purified with the QIAquick PCR purification kit (Qiagen, Valencia, CA). Sequencing was by dye-termination chemistry on an ABI 3730 DNA sequencer (Applied Biosystems), with subsequent sequence analysis using Sequencher (Gene Codes Corporation, Ann Arbor, MI).
###end p 21
###begin title 22
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPHP6</italic>
NPHP6 IVS26 c.2991+1655 mutation screening
###end title 22
###begin p 23
###xml 118 123 118 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPHP6</italic>
###xml 296 301 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPHP6</italic>
In the northern American population, the single most common LCA-associated mutation is a deletion within intron 26 of NPHP6 (IVS26 c.2991+1655). Therefore a screen of this mutation was conducted in parallel to the SNPlex assay. The presence or absence of the c.2991+1655 mutation in intron 26 of NPHP6 was assessed by bidirectional sequencing of genomic DNA from each unrelated affected individual. Only those also studied through the SNPlex assay (n=38) were included in this report. Reaction conditions and sequence analysis were as described in the previous section, except annealing conditions were as follows: 30 s, with 65 degreesC for the first cycle, reducing in temperature increments over the next nine cycles to 60 degreesC, followed by 25 cycles at 60 degreesC.
###end p 23
###begin title 24
Results
###end title 24
###begin p 25
###xml 268 275 268 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 284 286 284 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 374 379 374 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPHP6</italic>
###xml 131 139 <span type="species:ncbi:9606">patients</span>
The presence or absence of 103 LCA-causing mutations was successfully assayed with an allele-specific ligation assay applied to 38 patients with LCA from southern India. Genotype was determined in 3,755 of 3,914 tests, giving a sensitivity of 95.9% for these alleles (Table 1; the 104th allele was assayed only by bidirectional sequencing, please see paragraph referring to NPHP6 below). Of these disease-causing mutations previously found in the northern American population, only one example was identified in the cohort from South India.
###end p 25
###begin p 26
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPE65</italic>
###xml 80 88 80 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 96 103 <span type="species:ncbi:9606">patient</span>
###xml 458 463 <span type="species:ncbi:9606">child</span>
Patient ILCA-65-1 was homozygous for the mutation (Tyr368His TAT>CAT) in RPE65 (Figure 1). This patient presented at the Aravind Eye Institute at 3 years of age with a history of poor vision. On examination, visual acuity was 20/80 (6/24) in the right eye and 20/200 (6/60) in the left eye. Both dark-adapted scotopic and light-adapted photopic electroretinograms were nonrecordable. At age 9, pigmentary changes were observed in the midperiphery of the the child's fundus. Unaffected parents and an affected sibling were available for study. The affected sibling was examined at 2 years of age and had visual acuities of 20/120 (6/36) in the right eye and 20/160 (6/48) in the left eye, extinguished electroretinogram responses, and pigmentary retinopathy. The presence of this mutation was confirmed with bidirectional DNA sequencing and the phase established in available samples from relatives. Both unaffected parents were found to carry a heterozygous Tyr368His mutation, while the affected sibling was homozygous for the Tyr368His mutation.
###end p 26
###begin p 27
###xml 136 137 136 137 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 386 387 386 387 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 519 520 519 520 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 563 568 563 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPE65</italic>
###xml 753 758 753 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPE65</italic>
###xml 32 39 <span type="species:ncbi:9606">patient</span>
Clinical and molecular data for patient ILCA-65-1 and family. The proband first presented for ophthalmic examination at 3 years of age. A: There were no recordable responses to light in the electroretinogram. Examples shown are from the left eye for a dark-adapted combined response and a light-adapted photopic response. Arrowhead points to the timing of the 10-ms bright light pulse. B: The family tree shows the proband (filled circle with arrow) and a sibling as clinically affected and both parents as unaffected. C: Bidirectional sequencing showed that the RPE65 Tyr368His TAT>CAT mutation was homozygous in the affected proband (S1) and affected sibling (S3), and was heterozygous in the mother (M) and father (F). Reverse strand sequence around RPE65 Tyr368 (caNatct) is shown against an ethnic unrelated and unaffected control normal (NL).
###end p 27
###begin p 28
###xml 143 148 143 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPE65</italic>
###xml 313 318 313 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPE65</italic>
###xml 412 420 412 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 161 168 <span type="species:ncbi:9606">patient</span>
###xml 423 430 <span type="species:ncbi:9606">Patient</span>
###xml 547 553 <span type="species:ncbi:9606">infant</span>
###xml 592 599 <span type="species:ncbi:9606">patient</span>
###xml 719 726 <span type="species:ncbi:9606">patient</span>
In one instance, a mutation detected by the allele-specific assay was not confirmed by subsequent DNA sequencing. A Glu102STOP mutation in the RPE65 gene of one patient (ILCA-100-1) was suggested by the allele-specific assay. However, DNA sequencing showed this to be a false positive, and identified a different RPE65 mutation that was not included on our allele-specific assay (a homozygous Tyr143Asp TAC>GAC; Figure 2). Patient ILCA-100-1 was first presented at the Aravind Eye Institute at 4 months of age with the mother's complaint that the infant was not fixating on the her face. The patient was full term at birth, with normal delivery and no remarkable antenatal or perinatal problems. At 3 years of age, the patient's examination was consistent with LCA: severe visual impairment with nonrecordable electroretinogram in both eyes, normal anterior segment, and abnormal pigmentation in all four quadrants of the fundus with mild temporal pallor of the discs in both eyes. At age 4, on a recent follow-up, the subject was found to have a visual acuity of 20/120 (6/36) with both eyes open, and has achieved otherwise normal developmental milestones. Again, family history identified consanguinity, and both unaffected parents were found to be heterozygous for the Tyr143Asp mutation.
###end p 28
###begin p 29
###xml 171 175 171 175 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A),</bold>
###xml 419 420 419 420 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 540 541 540 541 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 584 589 584 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPE65</italic>
###xml 746 751 746 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPE65</italic>
###xml 32 39 <span type="species:ncbi:9606">patient</span>
Clinical and molecular data for patient ILCA-100-1 and family. The proband first presented for ophthalmic examination at 4 months of age. When the proband was 3 years old (A), there were no recordable responses to light in the electroretinogram. Examples shown are from the left eye for a dark-adapted combined response and a light-adapted photopic response. Arrowhead marks the timing of the 10-ms bright light pulse. B: The family tree shows the proband (filled circle with arrow) as clinically affected, and both parents are unaffected. C: Bidirectional sequencing showed that the RPE65 Tyr143Asp TAC>GAC mutation was homozygous in the affected proband (P) and was heterozygous in the mother (M) and father (F). Reverse strand sequence around RPE65 Tyr143 (atNacta) is shown against an ethnic unrelated and unaffected control normal (NL).
###end p 29
###begin p 30
###xml 96 101 96 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPHP6</italic>
###xml 26 34 <span type="species:ncbi:9606">patients</span>
The same cohort of 38 LCA patients were tested for the c.2991+1655 A>G mutation in intron 26 of NPHP6 with bidirectional DNA sequencing. No instances of this mutation were detected.
###end p 30
###begin title 31
Discussion
###end title 31
###begin p 32
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
LCA is a heterogeneous condition that is responsible for severe vision loss at birth. In the past 10 years great progress has been made in identifying the genes that are responsible for this condition. Mutations in the eight genes we studied in the South Indian population account for 64% of LCA in the United States [18].
###end p 32
###begin p 33
###xml 97 105 <span type="species:ncbi:9606">patients</span>
###xml 320 328 <span type="species:ncbi:9606">patients</span>
In the current study, we explored the role of previously discovered LCA mutations in a cohort of patients from southern India by testing for the presence of 104 previously reported mutations in eight LCA genes. While this particular set of mutations has been associated with roughly 30% of LCA cases in prior studies of patients from northern America, only one proband in the cohort from southern India (ILCA-65-1) was found to carry one of these 104 mutations previously associated with LCA.
###end p 33
###begin p 34
###xml 83 88 83 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPE65</italic>
###xml 497 504 <span type="species:ncbi:9606">patient</span>
###xml 599 606 <span type="species:ncbi:9606">patient</span>
Our SNPlex assay incidentally detected a plausible disease-causing mutation in the RPE65 gene that was not one of the 103 alleles included in the original assay design. A homozygous Tyr143Asp mutation was identified in subject ILCA-100-1. Segregation of the mutation with disease in the family supports the Tyr143Asp mutation as the cause of disease in this subject. Although we had not previously observed Tyr143Asp in LCA, we have observed Tyr143Asp as one of the disease-causing mutations in a patient categorized as having early onset retinitis pigmentosa. The relatively good vision for an LCA patient and early pigmentary changes of ILCA-100-1 illustrate the potential for overlap in these clinical categories when the cause of disease can be traced to mutations in the same gene.
###end p 34
###begin p 35
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 375 381 375 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GUCY2D</italic>
###xml 383 388 383 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPE65</italic>
###xml 390 394 390 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRB1</italic>
###xml 396 401 396 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AIPL1</italic>
###xml 403 406 403 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRX</italic>
###xml 408 413 408 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RDH12</italic>
###xml 415 421 415 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPGRIP</italic>
###xml 426 431 426 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPHP6</italic>
###xml 624 628 624 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LCA5</italic>
###xml 632 635 632 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RD3</italic>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 51 59 <span type="species:ncbi:9606">patients</span>
###xml 304 311 <span type="species:ncbi:9606">patient</span>
###xml 329 337 <span type="species:ncbi:9606">patients</span>
###xml 673 681 <span type="species:ncbi:9606">patients</span>
###xml 890 898 <span type="species:ncbi:9606">patients</span>
###xml 975 983 <span type="species:ncbi:9606">patients</span>
The lower prevalence of mutations in the cohort of patients from India is likely due in part to the high rate of novel mutations that are detected in LCA genes. In a prior study, 77% of disease-causing variations that were detected were only observed once [18]. Consequently, it is plausible that as for patient ILCA-100-1, many patients in our study have novel mutations in GUCY2D, RPE65, CRB1, AIPL1, CRX, RDH12, RPGRIP, or NPHP6 that were not included in the mutation-specific assay. Alternatively, it is possible that a large proportion of LCA cases from India are caused by mutations in novel or other known LCA genes (LCA5 or RD3) [10,22]. Thus, our Indian cohort of patients may be a useful resource for identifying additional novel LCA genes or new mutations in known LCA genes. Furthermore, our research suggests that mutation-specific assays that are designed from studies of LCA patients from one ethnic population are not the most efficient approach for studying patients from different populations and ethnic backgrounds.
###end p 35
###begin p 36
###xml 336 341 336 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPE65</italic>
###xml 385 390 385 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPE65</italic>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 48 56 <span type="species:ncbi:9606">patients</span>
###xml 231 239 <span type="species:ncbi:9606">patients</span>
###xml 482 490 <span type="species:ncbi:9606">patients</span>
The value of a detailed molecular screen of LCA patients from the Indian population lies in genetic counseling, improved diagnosis and prognosis, the support this gives to gene discovery efforts, and, more recently, in identifying patients for treatment. In both families with a molecular diagnosis from this study, the mutation was in RPE65, so the recent success of gene therapy for RPE65 presents a very real hope of treatment in the future that will improve the vision of these patients [23-25].
###end p 36
###begin title 37
Acknowledgments
###end title 37
###begin p 38
###xml 23 35 <span type="species:ncbi:9606">participants</span>
We sincerely thank the participants of this study. Support for this study came from the Aravind Medical Research Foundation and the Howard Hughes Medical Institute. ACK was supported by the Doris Duke Research Foundation. We thank Dr. Terry Braun (University of Iowa, Iowa City, IA) for assistance with the data analysis.
###end p 38
###begin title 39
References
###end title 39
###begin article-title 40
Mutations in a new photoreceptor-pineal gene on 17p cause Leber congenital amaurosis.
###end article-title 40
###begin article-title 41
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 34 44 <span type="species:ncbi:7227">Drosophila</span>
Mutations in a human homologue of Drosophila crumbs cause retinitis pigmentosa (RP12).
###end article-title 41
###begin article-title 42
De novo mutations in the CRX homeobox gene associated with Leber congenital amaurosis.
###end article-title 42
###begin article-title 43
Retinal-specific guanylate cyclase gene mutations in Leber's congenital amaurosis.
###end article-title 43
###begin article-title 44
Spectrum and frequency of mutations in IMPDH1 associated with autosomal dominant retinitis pigmentosa and leber congenital amaurosis.
###end article-title 44
###begin article-title 45
Mutations in LCA5, encoding the ciliary protein lebercilin, cause Leber congenital amaurosis.
###end article-title 45
###begin article-title 46
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Low prevalence of lecithin retinol acyltransferase mutations in patients with Leber congenital amaurosis and autosomal recessive retinitis pigmentosa.
###end article-title 46
###begin article-title 47
Mutations in the CEP290 (NPHP6) gene are a frequent cause of Leber congenital amaurosis.
###end article-title 47
###begin article-title 48
Retinal dehydrogenase 12 (RDH12) mutations in leber congenital amaurosis.
###end article-title 48
###begin article-title 49
Premature truncation of a novel protein, RD3, exhibiting subnuclear localization is associated with retinal degeneration.
###end article-title 49
###begin article-title 50
Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy.
###end article-title 50
###begin article-title 51
###xml 24 32 <span type="species:ncbi:9606">patients</span>
Null RPGRIP1 alleles in patients with Leber congenital amaurosis.
###end article-title 51
###begin article-title 52
###xml 37 45 <span type="species:ncbi:9606">patients</span>
Identification of novel mutations in patients with Leber congenital amaurosis and juvenile RP by genome-wide homozygosity mapping with SNP microarrays.
###end article-title 52
###begin article-title 53
Novel TULP1 mutation causing leber congenital amaurosis or early onset retinal degeneration.
###end article-title 53
###begin article-title 54
###xml 62 70 <span type="species:ncbi:9606">patients</span>
An assessment of the apex microarray technology in genotyping patients with Leber congenital amaurosis and early-onset severe retinal dystrophy.
###end article-title 54
###begin article-title 55
###xml 96 104 <span type="species:ncbi:9606">patients</span>
Clinical and molecular genetics of Leber's congenital amaurosis: a multicenter study of Italian patients.
###end article-title 55
###begin article-title 56
Frequency of CEP290 c.2991_1655A>G mutation in 175 Spanish families affected with Leber congenital amaurosis and early-onset retinitis pigmentosa.
###end article-title 56
###begin article-title 57
Leber congenital amaurosis - a model for efficient genetic testing of heterogeneous disorders: LXIV Edward Jackson Memorial Lecture.
###end article-title 57
###begin article-title 58
###xml 32 40 <span type="species:ncbi:9606">patients</span>
Mutation analysis of 3 genes in patients with Leber congenital amaurosis.
###end article-title 58
###begin article-title 59
###xml 52 60 <span type="species:ncbi:9606">patients</span>
RPE65 gene: multiplex PCR and mutation screening in patients from India with retinal degenerative diseases.
###end article-title 59
###begin article-title 60
###xml 55 60 <span type="species:ncbi:9606">human</span>
A simple salting out procedure for extracting DNA from human nucleated cells.
###end article-title 60
###begin article-title 61
Identification of a novel splice-site mutation in the Lebercilin (LCA5) gene causing Leber congenital amaurosis.
###end article-title 61
###begin article-title 62
Effect of gene therapy on visual function in Leber's congenital amaurosis.
###end article-title 62
###begin article-title 63
Safety and efficacy of gene transfer for Leber's congenital amaurosis.
###end article-title 63
###begin article-title 64
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics.
###end article-title 64

